{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:16:56Z","timestamp":1770221816393,"version":"3.49.0"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T00:00:00Z","timestamp":1511222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K50077X\/1"],"award-info":[{"award-number":["MR\/K50077X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["107731\/Z\/15\/Z"],"award-info":[{"award-number":["107731\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT101143MA"],"award-info":[{"award-number":["WT101143MA"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["205039\/Z\/16\/Z"],"award-info":[{"award-number":["205039\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002457","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T13:25:44Z","timestamp":1511270744000},"page":"e1002457","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort"],"prefix":"10.1371","volume":"14","author":[{"given":"Tom A.","family":"Yates","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie A.","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnan","family":"Bhaskaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinead","family":"Langan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liam","family":"Smeeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8970-1406","authenticated-orcid":true,"given":"Ian J.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"key":"ref1","unstructured":"WHO | Global tuberculosis report 2016. WHO. 2016;"},{"key":"ref2","unstructured":"Frick M. Treatment Action Group 2016 Report on Tuberculosis Research Funding Trends, 2005\u20132015: No Time to Lose. 2016 [cited 2017 Jul 24]; Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.treatmentactiongroup.org\/sites\/default\/files\/TB_FUNDING_2016_WEB.pdf\" xlink:type=\"simple\">http:\/\/www.treatmentactiongroup.org\/sites\/default\/files\/TB_FUNDING_2016_WEB.pdf<\/ext-link>. Accessed 2nd Nov 2017"},{"issue":"9924","key":"ref3","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0140-6736(13)62675-6","article-title":"Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: A cohort study","volume":"383","author":"E Pietersen","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"1602308","DOI":"10.1183\/13993003.02308-2016","article-title":"World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update","volume":"49","author":"D Falzon","year":"2017","journal-title":"Eur Respir J"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.chom.2014.09.008","article-title":"Anticytolytic screen identifies inhibitors of mycobacterial virulence protein secretion","volume":"16","author":"J Rybniker","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1038\/ncomms8659","article-title":"Lansoprazole is an antituberculous prodrug targeting cytochrome bc1","volume":"6","author":"J Rybniker","year":"2015","journal-title":"Nat Commun"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamainternmed.2015.7927","article-title":"Adverse Effects Associated With Proton Pump Inhibitors","volume":"176","author":"AJ Schoenfeld","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data Resource Profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"E Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12916-015-0381-9","article-title":"Risk of tuberculosis in patients with diabetes: population based cohort study using the UK Clinical Practice Research Datalink","volume":"13","author":"L Pealing","year":"2015","journal-title":"BMC Med"},{"key":"ref10","article-title":"Office for National Statistics: Key Health Statistics from General Practice 1998","year":"2000"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/ije\/dyr058","article-title":"The incubation period distribution of tuberculosis estimated with a molecular epidemiological approach","volume":"40","author":"MW Borgdorff","year":"2011","journal-title":"Int J Epidemiol"},{"key":"ref12","unstructured":"Public Health England. Tuberculosis in England 2015 report. London; 2015."},{"issue":"1645","key":"ref13","doi-asserted-by":"crossref","first-page":"20130437","DOI":"10.1098\/rstb.2013.0437","article-title":"The ongoing challenge of latent tuberculosis","volume":"369","author":"H Esmail","year":"2014","journal-title":"Philos Trans R Soc B Biol Sci"},{"issue":"suppl_2","key":"ref14","doi-asserted-by":"crossref","first-page":"ii40","DOI":"10.1093\/ndt\/gfw349","article-title":"Pharmacoepidemiology for nephrologists: do proton pump inhibitors cause chronic kidney disease?","volume":"32","author":"LA Tomlinson","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-230X-14-91","article-title":"Acid suppressive agents and risk of Mycobacterium Tuberculosis: case\u2013control study","volume":"14","author":"W-H Hsu","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"ref16","article-title":"Drug-Resistant Tuberculosis: A Survival Guide for Clinicians, 3rd edition","year":"2016"},{"issue":"5","key":"ref17","first-page":"827","article-title":"Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies","volume":"119","author":"GW Comstock","year":"1979","journal-title":"Am Rev Respir Dis"},{"issue":"14","key":"ref18","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1073\/pnas.1317660111","article-title":"Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings","volume":"111","author":"RMGJ Houben","year":"2014","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/QAD.0000000000001078","article-title":"Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapy","volume":"30","author":"T Sumner","year":"2016","journal-title":"AIDS"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/aje\/kwu320","article-title":"Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy","volume":"181","author":"E Vynnycky","year":"2015","journal-title":"Am J Epidemiol"},{"key":"ref21","unstructured":"University of Liverpool. HIV drug interactions."},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1365-2036.2004.01942.x","article-title":"Evaluation of the pharmacokinetics and pharmacodynamics of intravenous lansoprazole","volume":"19","author":"JW Freston","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"ref23","article-title":"Medical toxicology","author":"RC Dart","year":"2004"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T20:04:53Z","timestamp":1540325093000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002457"}},"subtitle":[],"editor":[{"given":"John Z.","family":"Metcalfe","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,21]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002457","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,21]]}}}